Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 151,434 | 133,451 | 113,788 | 105,197 | 68,570 |
| Marketable Securities | 38,691 | 41,980 | 33,403 | 22,329 | 21,585 |
| Receivables | 50,783 | 51,582 | 45,689 | 47,611 | 48,004 |
| Inventories | 69,801 | 69,382 | 75,086 | 75,199 | 75,541 |
| Income taxes - deferred | 15,616 | 15,505 | 13,934 | 13,934 | 14,035 |
| Other current assets | 5,819 | 5,801 | 6,114 | 5,950 | 5,998 |
| TOTAL | $332,144 | $317,701 | $288,014 | $270,220 | $233,733 |
| Non-Current Assets | |||||
| PPE Net | 50,872 | 48,763 | 49,455 | 49,631 | 49,512 |
| Investments And Advances | 20,345 | 8,708 | 15,572 | 24,193 | 24,888 |
| Intangibles | 3,826 | 3,818 | 56,157 | 0 | 0 |
| Other Non-Current Assets | 58,721 | 57,928 | 8,228 | 66,770 | 67,416 |
| TOTAL | $133,764 | $119,217 | $129,412 | $140,594 | $141,816 |
| Total Assets | $465,908 | $436,918 | $417,426 | $410,814 | $375,549 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,930 | 17,013 | 9,427 | 17,855 | 7,987 |
| Accrued Expenses | 57,405 | 51,497 | 43,395 | 58,486 | 47,911 |
| TOTAL | $88,173 | $77,812 | $70,274 | $91,116 | $70,250 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,356 | 8,318 | 7,662 | 13,811 | 13,402 |
| Other Non-Current Liabilities | 0 | 0 | 46 | 0 | 0 |
| TOTAL | $5,641 | $5,755 | $6,179 | $N/A | $N/A |
| Total Liabilities | $93,814 | $83,567 | $76,453 | $91,116 | $70,250 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 137,501 | 136,630 | 136,095 | 137,563 | 133,137 |
| Common Shares | 4,354 | 4,301 | 4,233 | 4,198 | 4,193 |
| Retained earnings | 212,012 | 195,322 | 183,260 | 170,503 | 158,020 |
| Other shareholders' equity | 652 | -2,041 | -2,868 | -4,127 | -4,719 |
| TOTAL | $372,094 | $353,351 | $340,973 | $319,698 | $305,299 |
| Total Liabilities And Equity | $465,908 | $436,918 | $417,426 | $410,814 | $375,549 |